Brasada Capital Management’s Medtronic MDT Stock Holding History

Brasada Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-74,096	Closed	-$6.4M	–	163
2026 Q1	$6.4M	Buy	74,096 +23,571	+47%	+$2.26M	1.17%	24
2025 Q4	$4.85M	Buy	50,525 +44,525	+742%	+$4.32M	0.82%	45
2025 Q3	$571K	Buy	+6,000	New	+$552K	0.1%	125
2020 Q2	–	Sell	-4,500	Closed	-$406K	–	148
2020 Q1	$406K	Buy	+4,500	New	+$479K	0.15%	95
2019 Q2	–	Sell	-6,500	Closed	-$592K	–	165
2019 Q1	$592K	Sell	6,500 -3,500	-35%	-$313K	0.18%	93
2018 Q4	$910K	Buy	10,000 +1,000	+11%	+$93.4K	0.3%	68
2018 Q3	$885K	Buy	9,000 +1,000	+13%	+$92.5K	0.24%	84
2018 Q2	$685K	Buy	8,000 +1,000	+14%	+$83.5K	0.21%	96
2018 Q1	$562K	Sell	7,000 -1,000	-13%	-$82.5K	0.17%	110
2017 Q4	$646K	Buy	+8,000	New	+$641K	0.22%	91

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Brasada Capital Management's MDT Position: Q2 2026 in Review

Brasada Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 74,096 shares — an estimated $6.4M sold.

Brasada Capital Management first reported a position in MDT in Q4 2017 and held it in 10 quarters. The position peaked at $6.4M in Q1 2026. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Brasada Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
Brasada Capital Management sold 74,096 Medtronic shares in Q2 2026, an estimated $6.4M.
Brasada Capital Management first reported a position in Medtronic in Q4 2017 and held it in 10 quarters.
Brasada Capital Management's Medtronic position peaked at $6.4M in Q1 2026.
2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Brasada Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.